CHING-WEI DAVIDTZENGCHING-WEI DAVID TZENG12722TZENG, CHING-WEI DAVIDAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson23991810Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MHHPB : the official journal of the International Hepato Pancreato Biliary AssociationSerum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). 2014 May; 16(5):430-8.HPB (Oxford)2013-08-29T00:00:002013Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.Palliative Care & Rehabilitation MedicineSurgical OncologyMD AndersonTHOMAS AALOIATHOMAS A ALOIA9087ALOIA, THOMAS AAssociate ProfessorANIRBANMAITRAANIRBAN MAITRA9915MAITRA, ANIRBANProfessorJEAN NICOLASVAUTHEYJEAN NICOLAS VAUTHEY8766VAUTHEY, JEAN NICOLASProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorMATTHEW HAROLDKATZMATTHEW HAROLD KATZ9338KATZ, MATTHEW HAROLDAssociate Professor22258816Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MHAnnals of surgical oncologyDefined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol. 2012 Jun; 19(6):2045-53.Ann Surg Oncol2012-01-19T00:00:002012Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.24112766Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PDHPB : the official journal of the International Hepato Pancreato Biliary AssociationNeoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford). 2014 Apr; 16(4):350-6.HPB (Oxford)2013-09-24T00:00:002013Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).23054896Tzeng CW, Aloia TAJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractColorectal liver metastases. J Gastrointest Surg. 2013 Jan; 17(1):195-201; quiz p.201-2.J Gastrointest Surg2012-10-03T00:00:002012Colorectal liver metastases.23408126Tzeng CW, Abbott DE, Cantor SB, Fleming JB, Lee JE, Pisters PW, Varadhachary GR, Abbruzzese JL, Wolff RA, Ahmad SA, Katz MHAnnals of surgical oncologyFrequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis. Ann Surg Oncol. 2013 Jul; 20(7):2197-203.Ann Surg Oncol2013-02-14T00:00:002013Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.23579874Tzeng CW, Vauthey JNAnnals of surgical oncologyPostoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track. Ann Surg Oncol. 2013 Aug; 20(8):2457-9.Ann Surg Oncol2013-08-01T00:00:002013Postoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track.23793524Cooper AB, Tzeng CW, Katz MHCurrent treatment options in oncologyTreatment of borderline resectable pancreatic cancer. Curr Treat Options Oncol. 2013 Sep; 14(3):293-310.Curr Treat Options Oncol2013-09-01T00:00:002013Treatment of borderline resectable pancreatic cancer.24241967Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractTreatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.J Gastrointest Surg2013-11-16T00:00:002013Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.24246619Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TAJournal of the American College of SurgeonsSystematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg. 2013 Dec; 217(6):1028-37.J Am Coll Surg2013-12-01T00:00:002013Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications.24410420Roses RE, Tzeng CW, Ross MI, Fournier KF, Abbott DE, You YNJournal of palliative medicineThe palliative index: predicting outcomes of emergent surgery in patients with cancer. J Palliat Med. 2014 Jan; 17(1):37-42.J Palliat Med2014-01-01T00:00:002014The palliative index: predicting outcomes of emergent surgery in patients with cancer.22568412Tzeng CW, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, Varadhachary G, Wolff RA, Katz MHHPB : the official journal of the International Hepato Pancreato Biliary AssociationYield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012 Jun; 14(6):365-72.HPB (Oxford)2012-02-28T00:00:002012Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy.23869628Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TAHPB : the official journal of the International Hepato Pancreato Biliary AssociationPredicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford). 2014 Apr; 16(4):373-83.HPB (Oxford)2013-07-22T00:00:002013Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients.24129825Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TAJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractMorbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. J Gastrointest Surg. 2014 Jan; 18(1):146-55; discussion 155-6.J Gastrointest Surg2013-10-16T00:00:002013Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification.24510523Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MAJournal of surgical oncologyIntraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol. 2014 Jun; 109(7):652-8.J Surg Oncol2014-02-10T00:00:002014Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.23397153Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JBAnnals of surgical oncologyThe cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.Ann Surg Oncol2013-02-10T00:00:002013The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.26350371Roland CL, Katz MH, Tzeng CW, Lin H, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Vauthey JN, Crane CH, Lee JE, Fleming JBAnnals of surgical oncologyThe Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1221-8.Ann Surg Oncol2015-09-08T00:00:002015The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.HOP S.TRAN CAOHOP S. TRAN CAO11366TRAN CAO, HOP S.Clinical Assistant Professor74Professor10Assistant Professor27Clinical Assistant Professor14Associate ProfessorMICHAELKIMMICHAEL KIM11768KIM, MICHAELAssistant Professor1515 Holcombe Blvd.Houston77030TX7.933810.00657369541research areas17.66560.0309754147coauthor of748.31171.942760similar to11281selected publicationsAuthorship 841244Authorship 842736Authorship 842877Authorship 844516Authorship 844957Authorship 846819Authorship 847690Authorship 854697Authorship 855883Authorship 857023Authorship 857036Authorship 857494Authorship 858316Authorship 858525Authorship 865250Authorship 865525Mastectomy. 409-422.MastectomySurgical Aspects of Pancreatic Cancer. 723-728.Surgical Aspects of Pancreatic CancerLiver anatomy, physiology, and preoperative evaluation. Liver anatomy, physiology, and preoperative evaluationAmerican Journal of SurgeryCancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. American Journal of Surgery. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinomaAnnals of SurgeryOpen Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach. Annals of Surgery. Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic ApproachJournal of Surgical OncologyBorderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. Journal of Surgical Oncology. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complicationsActa OncologicaImpact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncologica. 55:265-277.Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyJournal of Surgical OncologyDefining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma. Journal of Surgical Oncology. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinomaHPBIncreased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy. HPB. 17:846-854.Increased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomyCurrent Problems in SurgeryIn Brief. Current Problems in Surgery. 46:439-443.In BriefHPBLong-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma. HPB. 18:29-34.Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinomaHPBThromboelastography demonstrates perioperative hypercoagulability in hepato-pancreato-biliary patients and supports routine administration of preoperative and early postoperative venous thromboembolism chemoprophylaxis. HPB. Thromboelastography demonstrates perioperative hypercoagulability in hepato-pancreato-biliary patients and supports routine administration of preoperative and early postoperative venous thromboembolism chemoprophylaxisComplications of liver surgery including postoperative hepatic insufficiency. Complications of liver surgery including postoperative hepatic insufficiencyHPBPancreas fistula risk prediction. HPB. Pancreas fistula risk predictionAnnals of Surgical OncologyPositive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Annals of Surgical Oncology. 23:1003-1011.Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver MetastasesJournal of Gastrointestinal SurgerySSAT State-of-the-Art Conference. Journal of Gastrointestinal Surgery. 1-11.SSAT State-of-the-Art Conference29551247Mizuno T, Cloyd JM, Vicente D, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JNEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologySMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.Eur J Surg Oncol2018-03-07T00:00:002018SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.28767562Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CD, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JNAnnals of surgeryDeleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Ann Surg. 2019 05; 269(5):917-923.Ann Surg2019-05-01T00:00:002019Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.29454099Mizuno T, Cloyd JM, Omichi K, Chun YS, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JNJournal of the American College of SurgeonsTwo-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases. J Am Coll Surg. 2018 05; 226(5):825-834.J Am Coll Surg2018-02-14T00:00:002018Two-Stage Hepatectomy vs One-Stage Major Hepatectomy with Contralateral Resection or Ablation for Advanced Bilobar Colorectal Liver Metastases.Authorship 8864362Authorship 8864371Authorship 8864672Authorship 8864681Authorship 8864821Authorship 8864831Authorship 8864891Authorship 8865481Authorship 8866971Authorship 8867332Authorship 8867531Authorship 8867632Authorship 8868672Authorship 8869201Authorship 8869321Authorship 8869382Authorship 8869523Authorship 8869551Authorship 8869634Authorship 8869641Authorship 8870881Authorship 8871012Authorship 8884589Authorship 8886463Authorship 8896888Authorship 8899846D016577Procedures1176900.721604PancreaticoduodenectomyD010180Procedures1516530.705529PancreatectomyD010190Disorders69850490.284554Pancreatic NeoplasmsD021441Disorders30517220.439946Carcinoma, Pancreatic DuctalAuthorship 8976632Authorship 8976721Authorship 8977381Authorship 8978661Authorship 8986021Authorship 8987571Authorship 8991035Authorship 8991274Authorship 8993232Authorship 8998285Authorship 9000813Authorship 9001722Authorship 9001749Authorship 9004224Authorship 9022365Authorship 9027345Authorship 90412813Authorship 9043345Authorship 9055322Authorship 9062793Authorship 9072503Authorship 9079012Authorship 9085805Authorship 9091019Authorship 9101415Authorship 9101537Authorship 9108496Authorship 91249311Authorship 9134786Authorship 9135744Authorship 9137115Authorship 91387610Authorship 9144258Authorship 91452011Authorship 9148483Authorship 9167345Authorship 9168693Authorship 9198877Authorship 92027115Authorship 92058513Authorship 9210902Authorship 9211985Authorship 9221104Authorship 9227867Authorship 92305110Authorship 9231067Authorship 9232125Authorship 9233281Authorship 9233339Authorship 9233921Authorship 9235905Authorship 9247295Authorship 9271454Authorship 9271824Authorship 9280703Authorship 9284435Authorship 92930710Authorship 9298498Authorship 9298903Authorship 9304117Authorship 9305006Authorship 9325598Authorship 9325686Authorship 93354511Authorship 93367911Authorship 9338299Authorship 9338709Authorship 93406715Authorship 9342599Authorship 93467612Authorship 9363213Authorship 9367668Authorship 9373745Authorship 93758512Authorship 93947312Authorship 939719416925491Tzeng CW, Fiveash JB, Heslin MJExpert review of anticancer therapyRadiation therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther. 2006 Aug; 6(8):1251-60.Expert Rev Anticancer Ther2006-08-01T00:00:002006Radiation therapy for retroperitoneal sarcoma.16675563Li YC, Tzeng CC, Song JH, Tsia FJ, Hsieh LJ, Liao SJ, Tsai CH, Van Meir EG, Hao C, Lin CCClinical cancer research : an official journal of the American Association for Cancer ResearchGenomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res. 2006 May 01; 12(9):2716-29.Clin Cancer Res2006-05-01T00:00:002006Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy.16752414Tzeng CW, Fiveash JB, Popple RA, Arnoletti JP, Russo SM, Urist MM, Bland KI, Heslin MJCancerPreoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006 Jul 15; 107(2):371-9.Cancer2006-07-15T00:00:002006Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.17383523Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Buchsbaum DJ, Vickers SM, Heslin MJ, Arnoletti JPSurgeryEpidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer. Surgery. 2007 Apr; 141(4):464-9.Surgery2007-01-22T00:00:002007Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.17453292Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JPAnnals of surgical oncologyPancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response. Ann Surg Oncol. 2007 Jul; 14(7):2150-8.Ann Surg Oncol2007-04-24T00:00:002007Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.17560519Tzeng CW, Smith JK, Heslin MJSurgical oncology clinics of North AmericaSoft tissue sarcoma: preoperative and postoperative imaging for staging. Surg Oncol Clin N Am. 2007 Apr; 16(2):389-402.Surg Oncol Clin N Am2007-04-01T00:00:002007Soft tissue sarcoma: preoperative and postoperative imaging for staging.17950068Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JPThe Journal of surgical researchEGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients. J Surg Res. 2007 Nov; 143(1):20-6.J Surg Res2007-11-01T00:00:002007EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.18646476Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJThe American surgeonRadiofrequency ablation for unresectable tumors of the liver. Am Surg. 2008 Jul; 74(7):594-600; discussion 600-1.Am Surg2008-07-01T00:00:002008Radiofrequency ablation for unresectable tumors of the liver.18829481Huang HY, West RB, Tzeng CC, van de Rijn M, Wang JW, Chou SC, Huang WW, Eng HL, Lin CN, Yu SC, Wu JM, Lu CC, Li CFClinical cancer research : an official journal of the American Association for Cancer ResearchImmunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation. Clin Cancer Res. 2008 Oct 01; 14(19):6023-32.Clin Cancer Res2008-10-01T00:00:002008Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.19423534Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AHCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyWnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery. Cancer Epidemiol Biomarkers Prev. 2009 May; 18(5):1562-9.Cancer Epidemiol Biomarkers Prev2009-05-01T00:00:002009Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.19414097Liles JS, Tzeng CW, Short JJ, Kulesza P, Heslin MJCurrent problems in surgeryRetroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. 2009 Jun; 46(6):445-503.Curr Probl Surg2009-06-01T00:00:002009Retroperitoneal and intra-abdominal sarcoma.19887491Huang HY, Li SH, Yu SC, Chou FF, Tzeng CC, Hu TH, Uen YH, Tian YF, Wang YH, Fang FM, Huang WW, Wei YC, Wu JM, Li CFClinical cancer research : an official journal of the American Association for Cancer ResearchHomozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors. Clin Cancer Res. 2009 Nov 15; 15(22):6963-72.Clin Cancer Res2009-11-03T00:00:002009Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors.20409020Fong Y, Lin YS, Liou CP, Li CF, Tzeng CCRespirology (Carlton, Vic.)Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene. Respirology. 2010 May; 15(4):700-5.Respirology2010-03-29T00:00:002010Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene.20409526Frolov A, Liles JS, Kossenkov AV, Tzeng CW, Jhala N, Kulesza P, Varadarajulu S, Eloubeidi M, Heslin MJ, Arnoletti JPAmerican journal of surgeryEpidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma. Am J Surg. 2010 Sep; 200(3):398-405.Am J Surg2010-04-21T00:00:002010Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.21761100Li CF, Fang FM, Wang JM, Tzeng CC, Tai HC, Wei YC, Li SH, Lee YT, Wang YH, Yu SC, Shiue YL, Chu PY, Wang WL, Chen LT, Huang HYAnnals of surgical oncologyEGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact. Ann Surg Oncol. 2012 Feb; 19(2):443-54.Ann Surg Oncol2011-07-15T00:00:002011EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.25451735Kim S, Maynard EC, Shah MB, Daily MF, Tzeng CW, Davenport DL, Gedaly RJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractRisk factors for 30-day readmissions after hepatectomy: analysis of 2444 patients from the ACS-NSQIP database. J Gastrointest Surg. 2015 Feb; 19(2):266-71.J Gastrointest Surg2014-12-02T00:00:002014Risk factors for 30-day readmissions after hepatectomy: analysis of 2444 patients from the ACS-NSQIP database.25667138Martin JT, Mahan A, Zwischenberger JB, McGrath PC, Tzeng CWJournal of the American College of SurgeonsShould gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients. J Am Coll Surg. 2015 Apr; 220(4):510-20.J Am Coll Surg2014-12-29T00:00:002014Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.26190389Martin JT, Mahan AL, Ferraris VA, Saha SP, Mullett TW, Zwischenberger JB, Tzeng CWThe Annals of thoracic surgeryIdentifying Esophagectomy Patients at Risk for Predischarge Versus Postdischarge Venous Thromboembolism. Ann Thorac Surg. 2015 Sep; 100(3):932-8; discussion 938.Ann Thorac Surg2015-07-17T00:00:002015Identifying Esophagectomy Patients at Risk for Predischarge Versus Postdischarge Venous Thromboembolism.26412296Khushman M, Dempsey N, Maldonado JC, Loaiza-Bonilla A, Velez M, Carcas L, Dammrich D, Hurtado-Cordovi J, Parajuli R, Pollack T, Harwood AP, Macintyre J, Tzeng CW, Merchan JR, Restrepo MH, Akunyili II, Ribeiro A, Narayanan G, Portelance L, Sleeman D, Levi JU, Lima CM, Hosein PJPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma. Pancreatology. 2015 Nov-Dec; 15(6):667-73.Pancreatology2015-09-12T00:00:002015Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.26223475Harris JW, Martin JT, Maynard EC, McGrath PC, Tzeng CWHPB : the official journal of the International Hepato Pancreato Biliary AssociationIncreased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy: an NSQIP propensity-score matched analysis. HPB (Oxford). 2015 Sep; 17(9):846-54.HPB (Oxford)2015-07-30T00:00:002015Increased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy: an NSQIP propensity-score matched analysis.26031251Hance JM, Harris JW, Neltner J, Vilchez V, Tzeng CW, Maynard E, Gedaly R, Shah MBThe American surgeonHepatobiliary mucinous cystadenoma resulting in biliary obstruction. Am Surg. 2015 Jun; 81(6):E238-9.Am Surg2015-06-01T00:00:002015Hepatobiliary mucinous cystadenoma resulting in biliary obstruction.26213211Labori KJ, Katz MH, Tzeng CW, Bj?rnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IPActa oncologica (Stockholm, Sweden)Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol. 2016; 55(3):265-77.Acta Oncol2015-07-25T00:00:002015Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.26511261Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CW, Vauthey JNAnnals of surgical oncologyPositive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016 Mar; 23(3):1003-11.Ann Surg Oncol2015-10-28T00:00:002015Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.26776848Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, Hosein PJ, Gedaly R, Maynard EHPB : the official journal of the International Hepato Pancreato Biliary AssociationLong-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford). 2016 Jan; 18(1):29-34.HPB (Oxford)2016-01-07T00:00:002016Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.27033253Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CW, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly RAmerican journal of surgeryCancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. Am J Surg. 2016 Aug; 212(2):238-45.Am J Surg2016-02-27T00:00:002016Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.27238300Saeed H, Hnoosh D, Huang B, Durbin EB, McGrath PC, Desimone P, Maynard E, Anthony LB, Dineen SP, Hosein PJ, Tzeng CWJournal of surgical oncologyDefining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis. J Surg Oncol. 2016 Sep; 114(4):451-5.J Surg Oncol2016-05-30T00:00:002016Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.27393742Le AT, Tzeng CWJournal of surgical oncologyDoes finding early recurrence improve outcomes, and at what cost? J Surg Oncol. 2016 Sep; 114(3):329-35.J Surg Oncol2016-07-08T00:00:002016Does finding early recurrence improve outcomes, and at what cost?27480411Torzilli G, Nagino M, Tzeng CD, Kingham TP, Alatise OI, Ayandipo OO, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg. 2017 01; 21(1):175-185.J Gastrointest Surg2016-08-01T00:00:002016SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery.27807846Kim BJ, Tzeng CD, Cooper AB, Vauthey JN, Aloia TAJournal of surgical oncologyBorderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol. 2017 Mar; 115(3):337-343.J Surg Oncol2016-11-03T00:00:002016Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications.27884544Abbott DE, Tzeng CW, McMillan MT, Callery MP, Kent TS, Christein JD, Behrman SW, Schauer DP, Hanseman DJ, Eckman MH, Vollmer CMHPB : the official journal of the International Hepato Pancreato Biliary AssociationPancreas fistula risk prediction: implications for hospital costs and payments. HPB (Oxford). 2017 02; 19(2):140-146.HPB (Oxford)2016-11-21T00:00:002016Pancreas fistula risk prediction: implications for hospital costs and payments.27894845Le AT, Harris JW, Maynard E, Dineen SP, Tzeng CDHPB : the official journal of the International Hepato Pancreato Biliary AssociationThromboelastography demonstrates perioperative hypercoagulability in hepato-pancreato-biliary patients and supports routine administration of preoperative and early postoperative venous thromboembolism chemoprophylaxis. HPB (Oxford). 2017 02; 19(2):154-161.HPB (Oxford)2016-11-25T00:00:002016Thromboelastography demonstrates perioperative hypercoagulability in hepato-pancreato-biliary patients and supports routine administration of preoperative and early postoperative venous thromboembolism chemoprophylaxis.28045744Kutlu OC, Lee JE, Katz MH, Tzeng CD, Wolff RA, Varadhachary GR, Vauthey JN, Fleming JB, Conrad CAnnals of surgeryOpen Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis. Ann Surg. 2018 03; 267(3):552-560.Ann Surg2018-03-01T00:00:002018Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis.28958732Omichi K, Mizuno T, Okuno M, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JNEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyLong term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol. 2017 Nov; 43(11):2129-2134.Eur J Surg Oncol2017-09-13T00:00:002017Long term outcome after resection of liver metastases from squamous cell carcinoma.28585106Omichi K, Yamashita S, Cloyd JM, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN, Tzeng CDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPortal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy. J Gastrointest Surg. 2018 01; 22(1):60-67.J Gastrointest Surg2017-06-05T00:00:002017Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy.28168387Vega EA, Yamashita S, Chun YS, Kim M, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad CAnnals of surgical oncologyEffective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer. Ann Surg Oncol. 2017 Jul; 24(7):1852.Ann Surg Oncol2017-02-06T00:00:002017Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer.28624029Le AT, Huang B, Hnoosh D, Saeed H, Dineen SP, Hosein PJ, Durbin EB, Kudrimoti M, McGrath PC, Tzeng CDThe Journal of surgical researchEffect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer. J Surg Res. 2017 06 15; 214:1-8.J Surg Res2017-03-18T00:00:002017Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.28624049Frohman HA, Martin JT, Le AT, Dineen SP, Tzeng CDThe Journal of surgical researchFailure to operate on resectable gastric cancer: implications for policy changes and regionalization. J Surg Res. 2017 06 15; 214:229-239.J Surg Res2017-03-31T00:00:002017Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.28733741Goumard C, Ogiso S, Okuno M, Fleming JB, Kim M, Tzeng CD, Vauthey JN, Lee JE, Conrad CSurgical endoscopyTips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc. 2018 04; 32(4):2149-2150.Surg Endosc2017-07-21T00:00:002017Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy.28746155Tzeng CD, Vauthey JNAnnals of surgeryEvaluation of New Classifications for Liver Surgery: Can Anatomic Granularity Predict Both Complexity and Outcomes of Hepatic Resection? Ann Surg. 2018 01; 267(1):24-25.Ann Surg2018-01-01T00:00:002018Evaluation of New Classifications for Liver Surgery: Can Anatomic Granularity Predict Both Complexity and Outcomes of Hepatic Resection?28943395Okuno M, Gourmard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad CHPB : the official journal of the International Hepato Pancreato Biliary AssociationPathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford). 2018 01; 20(1):57-63.HPB (Oxford)2017-09-22T00:00:002017Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival.28917012Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad CSurgical endoscopyOperative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018 04; 32(4):1776-1786.Surg Endosc2017-09-15T00:00:002017Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis.28980211Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CW, Kim M, Fleming JB, Vauthey JN, Katz MH, Lee JE, Conrad CAnnals of surgical oncologyPathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol. 2017 Dec; 24(13):3954-3963.Ann Surg Oncol2017-10-04T00:00:002017Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.29116489Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad CAnnals of surgical oncologyLong-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol. 2018 Jan; 25(1):107-116.Ann Surg Oncol2017-11-07T00:00:002017Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases.29230694Cloyd JM, Nogueras-Gonz?lez GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CD, Fleming JB, Katz MHGJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractAnthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. J Gastrointest Surg. 2018 04; 22(4):703-712.J Gastrointest Surg2017-12-11T00:00:002017Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.29234998Patel SH, Kim BJ, Tzeng CD, Chun YS, Conrad C, Vauthey JN, Aloia TAJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractReduction of Cardiopulmonary/Renal Complications with Serum BNP-Guided Volume Status Management in Posthepatectomy Patients. J Gastrointest Surg. 2018 03; 22(3):467-476.J Gastrointest Surg2017-10-11T00:00:002017Reduction of Cardiopulmonary/Renal Complications with Serum BNP-Guided Volume Status Management in Posthepatectomy Patients.28700784Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHGJAMA surgeryAssociation of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2017 Nov 01; 152(11):1048-1056.JAMA Surg2017-11-01T00:00:002017Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.28688518Omichi K, Cloyd JM, Yamashita S, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JNSurgeryNeutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. 2017 10; 162(4):752-765.Surgery2017-07-05T00:00:002017Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma.28752405Vega EA, Vinuela E, Yamashita S, Sanhueza M, Cavada G, Diaz C, Aloia TA, Chun YS, Tzeng CD, Okuno M, Goumard C, Vauthey JN, Lee JE, Conrad CJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractExtended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status. J Gastrointest Surg. 2018 01; 22(1):43-51.J Gastrointest Surg2017-07-27T00:00:002017Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status.29626307Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari AAnnals of surgical oncologyPreoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 Jun; 25(6):1709-1715.Ann Surg Oncol2018-04-06T00:00:002018Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.29672417Katz MH, Kim MP, Tzeng CW, Lee JEAnnals of surgeryPreoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard? Ann Surg. 2018 08; 268(2):223-224.Ann Surg2018-08-01T00:00:002018Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?29807648Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHGSurgeryRisk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018 09; 164(3):424-431.Surgery2018-05-25T00:00:002018Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy.29370450Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJCancerImaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer. 2018 04 15; 124(8):1701-1709.Cancer2018-01-25T00:00:002018Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.29723419Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CDJournal of surgical oncologyVein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis. J Surg Oncol. 2018 Jun; 117(8):1648-1654.J Surg Oncol2018-05-03T00:00:002018Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis.29208318Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JNEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyLiver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018 01; 44(1):122-129.Eur J Surg Oncol2017-11-24T00:00:002017Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.30084064Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival. J Gastrointest Surg. 2019 01; 23(1):84-92.J Gastrointest Surg2018-08-06T00:00:002018Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.30100391Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad CHPB : the official journal of the International Hepato Pancreato Biliary AssociationLong-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford). 2019 03; 21(3):361-369.HPB (Oxford)2018-08-09T00:00:002018Long-term survival after post-hepatectomy liver failure for colorectal liver metastases.29987602Vicente D, Ikoma N, Chiang YJ, Fournier K, Tzeng CD, Song S, Mansfield P, Ajani J, Badgwell BDAnnals of surgical oncologyPreoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy. Ann Surg Oncol. 2018 Sep; 25(9):2720-2730.Ann Surg Oncol2018-07-09T00:00:002018Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.30197278Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad CSurgeryLoss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. 2019 02; 165(2):329-336.Surgery2018-09-06T00:00:002018Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.30266496Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad CHPB : the official journal of the International Hepato Pancreato Biliary AssociationConceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford). 2019 01; 21(1):43-50.HPB (Oxford)2018-09-25T00:00:002018Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy.30324485Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GRAnnals of surgical oncologyFirst-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):619-627.Ann Surg Oncol2018-10-15T00:00:002018First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.30339628Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JNAnnals of surgeryComprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies. Ann Surg. 2020 04; 271(4):724-731.Ann Surg2020-04-01T00:00:002020Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.29786130Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad CAnnals of surgical oncologyRAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2018 Aug; 25(8):2457-2466.Ann Surg Oncol2018-05-21T00:00:002018RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.29804864Lam A, Heslin MJ, Tzeng CD, Chen HThe Journal of surgical researchThe effects of tenure and promotion on surgeon productivity. J Surg Res. 2018 07; 227:67-71.J Surg Res2018-03-12T00:00:002018The effects of tenure and promotion on surgeon productivity.29970528Peterson SL, Husnain M, Pollack T, Pimentel A, Loaiza-Bonilla A, Westendorf-Overley C, Ratermann K, Anthony L, Desimone P, Goel G, Kudrimoti M, Dineen S, Tzeng CD, Hosein PJAnticancer researchNeoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX. Anticancer Res. 2018 Jul; 38(7):4035-4039.Anticancer Res2018-07-01T00:00:002018Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.30100032Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CDThe Journal of surgical researchValidation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res. 2018 10; 230:148-154.J Surg Res2018-05-31T00:00:002018Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.30152073Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJCancer medicineDose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med. 2018 10; 7(10):4880-4892.Cancer Med2018-08-27T00:00:002018Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.30169392Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JNAnnals of surgeryComment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough". Ann Surg. 2019 08; 270(2):e35-e36.Ann Surg2019-08-01T00:00:002019Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".30224070Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHGAmerican journal of surgeryThe role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. 2019 07; 218(1):145-150.Am J Surg2018-09-06T00:00:002018The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.30711243Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad CHPB : the official journal of the International Hepato Pancreato Biliary AssociationIncidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford). 2019 08; 21(8):1046-1056.HPB (Oxford)2019-01-31T00:00:002019Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.30385653Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HAClinical cancer research : an official journal of the American Association for Cancer ResearchSingle-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res. 2019 Apr 01; 25(7):2194-2205.Clin Cancer Res2018-11-01T00:00:002018Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.30465224Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad CAnnals of surgical oncologyMiddle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy. Ann Surg Oncol. 2019 Jan; 26(1):296.Ann Surg Oncol2018-11-21T00:00:002018Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.30623155Cazacu IM, Singh BS, Tzeng CD, Tamm EP, Bhutani MSVideoGIE : an official video journal of the American Society for Gastrointestinal EndoscopyIs it tumor encasement or arterial dissection/thrombosis? EUS to the rescue! VideoGIE. 2019 Jan; 4(1):24-26.VideoGIE2019-01-01T00:00:002019Is it tumor encasement or arterial dissection/thrombosis? EUS to the rescue!30629022Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHGPancreasChemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis. Pancreas. 2019 02; 48(2):216-222.Pancreas2019-02-01T00:00:002019Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.30704808Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad CEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyPositive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol. 2019 Jun; 45(6):1061-1068.Eur J Surg Oncol2019-01-24T00:00:002019Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.30362064Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YSAnnals of surgical oncologyIntrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.Ann Surg Oncol2018-10-25T00:00:002018Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.30539487Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CDAnnals of surgical oncologyPancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):652.Ann Surg Oncol2018-12-11T00:00:002018Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.D006498Procedures17110070.605954HepatectomyPathologyDepartment of SurgerySurgery-General Surgery DivBaylor College of MedicineAuthorship 9412244Authorship 9416482Authorship 9420219Authorship 9420783Authorship 942142630859352Simoneau E, Katz MH, Lee JE, Tzeng CDAnnals of surgical oncologyASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion. Ann Surg Oncol. 2019 12; 26(Suppl 3):579-580.Ann Surg Oncol2019-03-11T00:00:002019ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion.30799277Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CDHPB : the official journal of the International Hepato Pancreato Biliary AssociationIs early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford). 2019 09; 21(9):1203-1210.HPB (Oxford)2019-02-22T00:00:002019Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.30806484Melstrom LG, Tzeng CDJournal of surgical oncologyMetastatic colorectal cancer: The reality of the present and the optimism of the future. J Surg Oncol. 2019 Apr; 119(5):547-548.J Surg Oncol2019-02-26T00:00:002019Metastatic colorectal cancer: The reality of the present and the optimism of the future.20647770Liles JS, Arnoletti JP, Tzeng CW, Howard JH, Kossenkov AV, Kulesza P, Heslin MJ, Frolov ACancer biology & therapyErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma. Cancer Biol Ther. 2010 Sep 15; 10(6):555-63.Cancer Biol Ther2010-09-15T00:00:002010ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.30820801Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHGJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSignificance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection. J Gastrointest Surg. 2020 02; 24(2):368-379.J Gastrointest Surg2019-02-28T00:00:002019Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.Authorship 94373810Authorship 9437738Authorship 94400113Authorship 9441381030522947Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CDHPB : the official journal of the International Hepato Pancreato Biliary AssociationContemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford). 2019 06; 21(6):662-668.HPB (Oxford)2018-12-03T00:00:002018Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.30499795Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CDAnnals of surgeryClinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. Ann Surg. 2020 07; 272(1):163-169.Ann Surg2020-07-01T00:00:002020Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.30501986Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CDHPB : the official journal of the International Hepato Pancreato Biliary AssociationPerioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. HPB (Oxford). 2019 07; 21(7):841-848.HPB (Oxford)2018-11-28T00:00:002018Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.30728909Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JPOncotargetImpact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget. 2019 Jan 15; 10(5):584-594.Oncotarget2019-01-15T00:00:002019Impact of epidural analgesia on the systemic biomarker response after hepatic resection.Authorship 9447401030937660Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CDAnnals of surgical oncologyEducating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits. Ann Surg Oncol. 2019 Jul; 26(7):2011-2018.Ann Surg Oncol2019-04-01T00:00:002019Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits.Authorship 94669714Authorship 9467931031065616Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JMVideoGIE : an official video journal of the American Society for Gastrointestinal EndoscopyNovel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE. 2019 May; 4(5):223-225.VideoGIE2019-04-29T00:00:002019Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.31065963Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CDAnnals of surgical oncologyIntraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma. Ann Surg Oncol. 2019 Aug; 26(8):2579.Ann Surg Oncol2019-05-07T00:00:002019Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma.31054911Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Kopetz S, Vauthey JNJournal of the American College of SurgeonsConditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019 09; 229(3):286-294.e1.J Am Coll Surg2019-05-02T00:00:002019Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.23377564Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JNAnnals of surgical oncologyOptimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013 Aug; 20(8):2493-500.Ann Surg Oncol2013-02-03T00:00:002013Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.Authorship 9484091131170555Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MHG, Hurd MW, Maitra A, Rhim Md AD, Tzeng CDThe Journal of surgical researchCirculating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. J Surg Res. 2019 11; 243:90-99.J Surg Res2019-06-03T00:00:002019Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.Authorship 9487405Authorship 9496596Authorship 9501231331210666Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CDPancreasBenefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. Pancreas. 2019 07; 48(6):837-843.Pancreas2019-07-01T00:00:002019Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.31221662Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JNClinical cancer research : an official journal of the American Association for Cancer ResearchMutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res. 2019 10 01; 25(19):5843-5851.Clin Cancer Res2019-06-20T00:00:002019Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.Authorship 9506931531243665Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CDAnnals of surgical oncologyInpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol. 2019 Oct; 26(11):3428-3435.Ann Surg Oncol2019-06-26T00:00:002019Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.Authorship 9511631531274655Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHGAnnals of surgeryRadiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. Ann Surg. 2021 04 01; 273(4):806-813.Ann Surg2021-04-01T00:00:002021Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer.Authorship 9535881931398337Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister FCellTumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019 08 08; 178(4):795-806.e12.Cell2019-08-08T00:00:002019Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.Authorship 9548421231478982Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CDAnnals of surgeryOpioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg. 2020 02; 271(2):e9-e10.Ann Surg2020-02-01T00:00:002020Opioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action.Authorship 9556562Authorship 955729631529310Lillemoe HA, Tzeng CDAnnals of surgical oncologyASO Author Reflections: Opioid Prescribing in Surgical Oncology-Institutional Opportunities for Educational Interventions. Ann Surg Oncol. 2019 12; 26(Suppl 3):731-732.Ann Surg Oncol2019-09-16T00:00:002019ASO Author Reflections: Opioid Prescribing in Surgical Oncology-Institutional Opportunities for Educational Interventions.31533893Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JNHPB : the official journal of the International Hepato Pancreato Biliary AssociationCharacteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? HPB (Oxford). 2020 04; 22(4):545-552.HPB (Oxford)2019-09-16T00:00:002019Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?Authorship 956137231559543Newhook TE, Tzeng CDAnnals of surgical oncologyASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol. 2019 12; 26(Suppl 3):749-750.Ann Surg Oncol2019-09-26T00:00:002019ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.Authorship 9568631331592772Parker NH, Lee RE, O'Connor DP, Ngo-Huang A, Petzel MQB, Schadler K, Wang X, Xiao L, Fogelman D, Simpson R, Fleming JB, Lee JE, Tzeng CD, Sahai SK, Basen-Engquist K, Katz MHGJournal of physical activity & healthSupports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study. J Phys Act Health. 2019 12 01; 16(12):1113-1122.J Phys Act Health2019-10-07T00:00:002019Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study.true1Clinical Assistant ProfessorClinical Assistant ProfessorAuthorship 960623831695849Vicente D, Patino M, Marcus R, Lillemoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JPOncotargetCorrection: Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget. 2019 Oct 29; 10(59):6397.Oncotarget2019-10-29T00:00:002019Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection.Authorship 9610561231727324Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CDSurgeryEarly postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery. 2020 02; 167(2):442-447.Surgery2019-11-11T00:00:002019Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge.Authorship 9626961331843190Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CDAmerican journal of surgeryPostoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg. 2020 07; 220(1):140-146.Am J Surg2019-11-30T00:00:002019Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection.Authorship 9750911431895709Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHGAnnals of surgeryPostoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Ann Surg. 2020 06; 271(6):996-1002.Ann Surg2020-06-01T00:00:002020Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.Authorship 976700431997073Denbo JW, Kim BJ, Vauthey JN, Tzeng CW, Ma J, Huang SY, Chun YS, Katz MHG, Aloia TAJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractOverall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization. J Gastrointest Surg. 2021 02; 25(2):405-410.J Gastrointest Surg2020-01-29T00:00:002020Overall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization.Authorship 9789286Authorship 9790938Authorship 979896632144462Niekamp AS, Huang SY, Mahvash A, Odisio BC, Ahrar K, Tzeng CD, Vauthey JNEuropean radiologyHepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol. 2020 Jul; 30(7):3862-3868.Eur Radiol2020-03-07T00:00:002020Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma.32149390Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CWJournal of surgical oncologyClinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28.J Surg Oncol2020-03-09T00:00:002020Clinical trials-Designing, implementing, and collaborating.32162236Joechle K, Vreeland TJ, Vega EA, Okuno M, Newhook TE, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Lee JE, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractAnatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg. 2020 05; 24(5):1033-1039.J Gastrointest Surg2020-03-10T00:00:002020Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation.Authorship 9865956Authorship 9867071432253074Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JNEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyHepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. 2020 09; 46(9):1588-1595.Eur J Surg Oncol2020-03-28T00:00:002020Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.32266574Perri G, Prakash L, Malleo G, Caravati A, Varadhachary GR, Fogelman D, Pant S, Koay EJ, Herman J, Maggino L, Milella M, Kim M, Ikoma N, Tzeng CW, Salvia R, Lee JE, Bassi C, Katz MHGAnnals of surgical oncologyThe Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer. Ann Surg Oncol. 2020 Oct; 27(10):3939-3947.Ann Surg Oncol2020-04-07T00:00:002020The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer.Authorship 9901461032447769Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, Aloia TA, Vauthey JN, Lee JE, Tzeng CDJournal of surgical oncologyEducating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol. 2020 Sep; 122(3):547-554.J Surg Oncol2020-05-23T00:00:002020Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention.Authorship 991542632524634Shah MM, Meyer BI, Rhee K, NeMoyer RE, Lin Y, Tzeng CD, Jabbour SK, Kennedy TJ, Nosher JL, Kooby DA, Maithel SK, Carpizo DRJournal of surgical oncologyConditional survival analysis of hepatocellular carcinoma. J Surg Oncol. 2020 Sep; 122(4):684-690.J Surg Oncol2020-06-10T00:00:002020Conditional survival analysis of hepatocellular carcinoma.Authorship 993746932632993Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CDJournal of surgical oncologyPerceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership. J Surg Oncol. 2020 Nov; 122(6):1066-1073.J Surg Oncol2020-07-06T00:00:002020Perceptions of opioid use and prescribing habits in oncologic surgery: A survey of the society of surgical oncology membership.Authorship 99441714Authorship 9945551Authorship 994559432667641Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHGJAMA surgeryResponse and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2020 09 01; 155(9):832-839.JAMA Surg2020-09-01T00:00:002020Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.32675511Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JNAnnals of surgeryCancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.Ann Surg2020-08-01T00:00:002020Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience.32675519Day RW, Taylor BM, Bednarski BK, Tzeng CD, Gershenwald JE, Lee JE, Grubbs EGAnnals of surgeryVirtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations. Ann Surg. 2020 08; 272(2):e144-e147.Ann Surg2020-08-01T00:00:002020Virtual Interviews for Surgical Training Program Applicants During COVID-19: Lessons Learned and Recommendations.Authorship 9972731132805403Ikoma N, Kim MP, Tzeng CD, Tran Cao HS, Lee JE, Katz MHGJournal of the American College of SurgeonsExternal Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg. 2020 11; 231(5):e8-e10.J Am Coll Surg2020-08-14T00:00:002020External Retraction Technique for Robotic Pancreatoduodenectomy.32803553Newhook TE, Soliz JM, Prakash LR, Hancher-Hodges S, Speer BB, Wilks JA, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CDAnnals of surgical oncologyImpact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Mar; 28(3):1563-1569.Ann Surg Oncol2020-08-16T00:00:002020Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma.Authorship 998597232880772Newhook TE, Tzeng CDAnnals of surgical oncologyASO Author Reflections: Tumor Biology and Safe Surgery Remain Major Determinants of Survival After Resection of Pancreatic Adenocarcinoma. Ann Surg Oncol. 2021 Mar; 28(3):1570-1571.Ann Surg Oncol2020-09-03T00:00:002020ASO Author Reflections: Tumor Biology and Safe Surgery Remain Major Determinants of Survival After Resection of Pancreatic Adenocarcinoma.Authorship 9990591Authorship 999083532891326Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JNSurgical oncologySurgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.Surg Oncol2020-04-28T00:00:002020Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach.32892137Kemp Bohan PM, Chick RC, Wall ME, Hale DF, Tzeng CD, Peoples GE, Vreeland TJ, Clifton GTThe Journal of surgical researchAn Educational Intervention Reduces Opioids Prescribed Following General Surgery Procedures. J Surg Res. 2021 01; 257:399-405.J Surg Res2020-09-03T00:00:002020An Educational Intervention Reduces Opioids Prescribed Following General Surgery Procedures.Authorship 10007153Authorship 1001103732997105Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CDJAMA surgeryAssessing the 5?-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery. JAMA Surg. 2020 12 01; 155(12):1166-1167.JAMA Surg2020-12-01T00:00:002020Assessing the 5?-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient Surgery.Authorship 10022642133027788Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AOOncologyImpact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology. 2020; 98(12):836-846.Oncology2020-10-07T00:00:002020Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.Authorship 1002896233062624Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JNJournal of hepatocellular carcinomaSurgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization. J Hepatocell Carcinoma. 2020; 7:155-158.J Hepatocell Carcinoma2020-09-28T00:00:002020Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization.Authorship 10043689Authorship 10045346Authorship 10050308Authorship 10052254Authorship 10054606Authorship 10056741033138060Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma NJournal of clinical medicineTreatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med. 2020 Oct 29; 9(11).J Clin Med2020-10-29T00:00:002020Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States.33205306Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Dasari A, Kopetz S, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractAlteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.J Gastrointest Surg2020-11-17T00:00:002020Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.33152698Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Vauthey JNJournal of the National Comprehensive Cancer Network : JNCCNA New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw. 2020 11; 18(11):1500-1508.J Natl Compr Canc Netw2020-11-02T00:00:002020A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.33221151Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology. 2021 Jan; 21(1):200-207.Pancreatology2020-11-14T00:00:002020Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.33236322Arango NP, Prakash LR, Chiang YJ, Dewhurst WL, Bruno ML, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractRisk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying. J Gastrointest Surg. 2021 09; 25(9):2221-2230.J Gastrointest Surg2020-11-24T00:00:002020Risk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying.33188051Colina A, Hwang H, Wang H, Katz MHG, Sun R, Lee JE, Thomas J, Tzeng CW, Wolff RA, Raghav K, Overman MJESMO openNatural history and prognostic factors for localised small bowel adenocarcinoma. ESMO Open. 2020 11; 5(6):e000960.ESMO Open2020-11-01T00:00:002020Natural history and prognostic factors for localised small bowel adenocarcinoma.Authorship 10069695Authorship 10070464Authorship 1007049233324708Coronel M, Lanke G, Cambell D, Coronel E, Tzeng CD, Foo W, Lee JHACG case reports journalPerforming Endoscopic Retrograde Cholagiopancreatpgraphy and Endoscopic Ultrasound for Management of Malignant Bile Duct Obstruction in a Patient With a Situs Inversus Totalis. ACG Case Rep J. 2020 Dec; 7(12):e00483.ACG Case Rep J2020-12-07T00:00:002020Performing Endoscopic Retrograde Cholagiopancreatpgraphy and Endoscopic Ultrasound for Management of Malignant Bile Duct Obstruction in a Patient With a Situs Inversus Totalis.33330755Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CD, Vauthey JNGlobal health & medicineLong-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. Glob Health Med. 2019 Oct 31; 1(1):55-60.Glob Health Med2019-10-31T00:00:002019Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis.33330793Nishioka Y, Tzeng CD, Tran Cao HS, Vauthey JNGlobal health & medicineCOVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med. 2020 Apr 30; 2(2):135-137.Glob Health Med2020-04-30T00:00:002020COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States.Authorship 1007628533351476Lillemoe HA, Passot G, Kawaguchi Y, DeBellis M, Glehen O, Chun YS, Tzeng CD, Aloia TA, Lopez J, Vauthey JNAnnals of surgeryRAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease. Ann Surg. 2022 08 01; 276(2):357-362.Ann Surg2020-12-18T00:00:002020RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease.Authorship 100845010Authorship 10085151133415562White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CDAnnals of surgical oncologyMeasurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4615-4622.Ann Surg Oncol2021-01-07T00:00:002021Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma.33418464Kemp Bohan PM, O'Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, Tzeng CD, Vreeland TJSurgical oncologyLymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.Surg Oncol2020-12-30T00:00:002020Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes.Authorship 1010037233507452White MG, Tzeng CDAnnals of surgical oncologyASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4623-4624.Ann Surg Oncol2021-01-28T00:00:002021ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma.Authorship 10110027Authorship 10110951033566248Kemp Bohan PM, O'Shea AE, Ellis OV, Chick RC, Clem AM, Kirby DT, Bader JO, Newhook TE, Clifton GT, Tzeng CD, Nelson DW, Vreeland TJAnnals of surgical oncologyRates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer. Ann Surg Oncol. 2021 Jun; 28(6):2960-2972.Ann Surg Oncol2021-02-10T00:00:002021Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer.33561722Allen CJ, Eska JS, Thaker NG, Feeley TW, Kaplan RS, Huey RW, Tzeng CD, Lee JE, Frank SJ, Aloia TA, Gottumukkala V, Katz MHGThe Journal of surgical researchDeveloping a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative. J Surg Res. 2021 06; 262:115-120.J Surg Res2021-02-06T00:00:002021Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative.Authorship 10115453Authorship 101280617Authorship 1012822233586068Mason MC, Massarweh NN, Tzeng CD, Chiang YJ, Chun YS, Aloia TA, Javle M, Vauthey JN, Tran Cao HSAnnals of surgical oncologyTime to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.Ann Surg Oncol2021-02-14T00:00:002021Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience.33666814Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JNAnnals of surgical oncologyConditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis. Ann Surg Oncol. 2021 May; 28(5):2675-2682.Ann Surg Oncol2021-03-05T00:00:002021Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis.33667566Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YSJournal of the American College of SurgeonsPreliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.J Am Coll Surg2021-03-02T00:00:002021Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases.Authorship 10143671033751605Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CDJournal of surgical oncologySustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. 2021 Jul; 124(1):143-151.J Surg Oncol2021-03-22T00:00:002021Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years.Authorship 10152265Authorship 10152377Authorship 10153365Authorship 10158611833831256Gaskill CE, Maxwell J, Ikoma N, Kim MP, Tzeng CW, Lee JE, Katz MHGJournal of surgical oncologyHistory of preoperative therapy for pancreatic cancer and the MD Anderson experience. J Surg Oncol. 2021 May; 123(6):1414-1422.J Surg Oncol2021-05-01T00:00:002021History of preoperative therapy for pancreatic cancer and the MD Anderson experience.33832821Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology. 2021 Aug; 21(5):942-949.Pancreatology2021-04-01T00:00:002021Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival.33774771Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HSAnnals of surgical oncologyRobotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol. 2021 Oct; 28(11):6834.Ann Surg Oncol2021-03-27T00:00:002021Robotic Completion Radical Cholecystectomy with Fluorescence Guidance.33811152Kanikarla Marie P, Haymaker C, Parra ER, Kim YU, Lazcano R, Gite S, Lorenzini D, Wistuba II, Tidwell RSS, Song X, Foo WC, Maru DM, Chun YS, Futreal A, Kee B, Menter D, Solis L, Tzeng CW, Parseghian C, Raghav K, Morris V, Chang CC, Jenq R, Tam A, Bernatchez C, Kopetz S, Vauthey JN, Overman MJClinical cancer research : an official journal of the American Association for Cancer ResearchPilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res. 2021 06 01; 27(11):3039-3049.Clin Cancer Res2021-04-02T00:00:002021Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases.Authorship 1017248533914451Kawaguchi Y, Newhook TE, Fuks D, Cao HST, Tzeng CD, Chun YS, Aloia TA, Gayet B, Vauthey JNAnnals of surgeryComment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis". Ann Surg. 2022 08 01; 276(2):e134-e135.Ann Surg2021-04-01T00:00:002021Comment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis".Authorship 1017754133952392Tzeng CDSurgerySynchronous colorectal liver metastases with asymptomatic primary tumors: An individualized sequencing approach remains ideal. Surgery. 2021 07; 170(1):319.Surgery2021-05-02T00:00:002021Synchronous colorectal liver metastases with asymptomatic primary tumors: An individualized sequencing approach remains ideal.Authorship 1020797734111531Kawaguchi Y, Kopetz S, Kwong L, Xiao L, Morris JS, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JNJournal of the American College of SurgeonsGenomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.J Am Coll Surg2021-06-07T00:00:002021Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer.Authorship 1024091634183508Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HSTAnnals of surgerySurgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race. Ann Surg. 2023 02 01; 277(2):321-328.Ann Surg2023-01-10T00:00:002023Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.Authorship 10249011734250759Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister FCancer medicineAntibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med. 2021 08; 10(15):5041-5050.Cancer Med2021-07-11T00:00:002021Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.Authorship 102788215Authorship 1028073234416414Fujii Y, Tzeng CW, Chiang YJ, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma NThe Journal of surgical researchIncidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. J Surg Res. 2021 12; 268:419-431.J Surg Res2021-08-17T00:00:002021Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors.34398988Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CDJournal of surgical oncologyPerioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. J Surg Oncol. 2021 Dec; 124(8):1381-1389.J Surg Oncol2021-08-16T00:00:002021Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy.Authorship 10282916Authorship 10284297Authorship 1028535434429247Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology. 2021 Oct; 21(7):1378-1385.Pancreatology2021-08-18T00:00:002021GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.34438236Nishioka Y, Odisio BC, Velasco JD, Ninan E, Huang SY, Mahvash A, Tzeng CD, Tran Cao HS, Gupta S, Vauthey JNSurgical oncologyFast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.Surg Oncol2021-08-16T00:00:002021Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite.34453259Fonseca AL, Cherla D, Kothari AN, Tzeng CD, Heslin MJ, Mehari KR, Johnston FM, Tran-Cao HSAnnals of surgical oncologyAssociation of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database. Ann Surg Oncol. 2022 Jan; 29(1):342-351.Ann Surg Oncol2021-08-27T00:00:002021Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database.Authorship 1029399734506029Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractImproved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg. 2022 03; 26(3):583-593.J Gastrointest Surg2021-09-10T00:00:002021Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer.Authorship 1029640634515886Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, Mansfield PF, Lee JE, Badgwell BD, Katz MHGAnnals of surgical oncologyEarly Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Ann Surg Oncol. 2022 Jan; 29(1):285.Ann Surg Oncol2021-09-13T00:00:002021Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy.Authorship 1033552734725784Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractNeither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.J Gastrointest Surg2021-11-01T00:00:002021Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.Authorship 103536811Authorship 10355056Authorship 10359591434894620Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CDSurgical oncologyAJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol. 2022 Mar; 40:101673.Surg Oncol2021-12-01T00:00:002021AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.34904258Witt RG, Cope B, Chiang YJ, Newhook T, Lillemoe H, Tzeng CD, Chen IB, Fisher SB, Lucci A, Wargo JA, Lee JE, Ross MI, Gershenwald JE, Robinson J, Keung EZJournal of surgical oncologyUtilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. J Surg Oncol. 2022 Mar; 125(4):719-729.J Surg Oncol2021-12-14T00:00:002021Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.34945742De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJJournal of personalized medicineBenchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med. 2021 Dec 01; 11(12).J Pers Med2021-12-01T00:00:002021Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma.Authorship 10372811435023033Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractIterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy. J Gastrointest Surg. 2022 05; 26(5):1054-1062.J Gastrointest Surg2022-01-12T00:00:002022Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy.Authorship 10383455Authorship 103858612Authorship 103915816Authorship 103985411Authorship 104035211Authorship 104036820Authorship 1040552535306260Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CDThe Journal of surgical researchAssociation of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy. J Surg Res. 2022 07; 275:244-251.J Surg Res2022-03-17T00:00:002022Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy.35097226Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJClinical and translational radiation oncologyNBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol. 2022 Mar; 33:66-69.Clin Transl Radiat Oncol2022-01-11T00:00:002022NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.35290266Nishioka Y, Chun YS, Overman MJ, Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, MD Anderson Cancer Center INTERCEPT ProgramJournal of the American College of SurgeonsEffect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2022 04 01; 234(4):474-483.J Am Coll Surg2022-04-01T00:00:002022Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases.35064457Vreeland TJ, Bohan PMK, Newhook TE, Allen CJ, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractContemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. J Gastrointest Surg. 2022 02; 26(2):352-359.J Gastrointest Surg2022-01-22T00:00:002022Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy.35065057Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma PThe lancet. Gastroenterology & hepatologyPerioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218.Lancet Gastroenterol Hepatol2022-01-20T00:00:002022Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.35080619Mallick S, Aiken T, Varley P, Abbott D, Tzeng CW, Weber S, Wasif N, Zafar SNJAMA surgeryReadmissions From Venous Thromboembolism After Complex Cancer Surgery. JAMA Surg. 2022 04 01; 157(4):312-320.JAMA Surg2022-04-01T00:00:002022Readmissions From Venous Thromboembolism After Complex Cancer Surgery.35157075Janssen QP, van Dam JL, Doppenberg D, Prakash LR, van Eijck CHJ, Jarnagin WR, O' Reilly EM, Paniccia A, Besselink MG, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Trans-Atlantic Pancreatic Surgery (TAPS) ConsortiumJournal of the National Cancer InstituteFOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium. J Natl Cancer Inst. 2022 05 09; 114(5):695-703.J Natl Cancer Inst2022-05-09T00:00:002022FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium.Authorship 10436269Authorship 1043862835417569De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJCancerAblative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.Cancer2022-04-13T00:00:002022Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.35397746Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HSAnnals of surgical oncologyOutcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.Ann Surg Oncol2022-04-10T00:00:002022Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection.22762398Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TAHPB : the official journal of the International Hepato Pancreato Biliary AssociationRisk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford). 2012 Aug; 14(8):506-13.HPB (Oxford)2012-05-15T00:00:002012Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients.22932858Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MAAnnals of surgical oncologyMorbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.Ann Surg Oncol2012-08-30T00:00:002012Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis.Authorship 1045074735507230Hirata Y, Witt RG, Prakash LR, Arvide EM, Robinson KA, Gottumukkala V, Tzeng CD, Mansfield P, Badgwell BD, Ikoma NAnnals of surgical oncologyAnalysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy. Ann Surg Oncol. 2022 Sep; 29(9):5861-5870.Ann Surg Oncol2022-05-04T00:00:002022Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy.23869577Tzeng CW, Curley SA, Vauthey JN, Aloia TAHPB : the official journal of the International Hepato Pancreato Biliary AssociationDistinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford). 2013 Oct; 15(10):773-80.HPB (Oxford)2013-07-22T00:00:002013Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients.24129824Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSafety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014 Jan; 18(1):45-51.J Gastrointest Surg2013-10-16T00:00:002013Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients.Authorship 10457712Authorship 1046091335538175Hirata Y, Tzeng CD, Ikoma NAnnals of surgical oncologyASO Author Reflections: Value of Robotic Surgery in the Era of Opioid Crisis. Ann Surg Oncol. 2022 09; 29(9):5871-5872.Ann Surg Oncol2022-05-10T00:00:002022ASO Author Reflections: Value of Robotic Surgery in the Era of Opioid Crisis.35578764Kim BJ, Newhook TE, Tzeng CD, Ikoma N, Chiang YJ, Chun YS, Vauthey JN, Tran Cao HSJournal of surgical oncologyLymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.J Surg Oncol2022-05-16T00:00:002022Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach.Authorship 10463771135597025DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N, Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CDThe Journal of surgical researchOpioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res. 2022 10; 278:111-118.J Surg Res2022-05-18T00:00:002022Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay.Authorship 10476221735663797DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, PROMOTE ConsortiumSurgery open scienceA prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci. 2022 Jul; 9:51-57.Surg Open Sci2022-04-25T00:00:002022A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients.Authorship 104811210Authorship 1048122535705775Gilbert RWD, Lenet T, Cleary SP, Smoot R, Tzeng CD, Rocha FG, Martel G, Bertens KAAnnals of surgical oncologyDoes Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2022 Oct; 29(11):6759-6771.Ann Surg Oncol2022-06-15T00:00:002022Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis.35703961DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CDJournal of the American College of SurgeonsProspective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 07 01; 235(1):41-48.J Am Coll Surg2022-04-11T00:00:002022Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery.Authorship 10487239Authorship 10488231335726394DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CDJournal of surgical oncologyPrognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol. 2022 Nov; 126(6):1021-1027.J Surg Oncol2022-06-20T00:00:002022Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first.35747509Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Phan TL, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CD, Newhook TESurgery open scienceRisk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci. 2022 Jul; 9:109-116.Surg Open Sci2022-05-08T00:00:002022Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay.Authorship 1049118435752725Lenet T, Gilbert RWD, Smoot R, Tzeng CD, Rocha FG, Yohanathan L, Cleary SP, Martel G, Bertens KAAnnals of surgical oncologyDoes Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis. Ann Surg Oncol. 2022 Nov; 29(12):7592-7602.Ann Surg Oncol2022-06-25T00:00:002022Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis.Authorship 105004111Authorship 1049954535797554Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JNAnnals of surgeryProspective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg. 2023 05 01; 277(5):813-820.Ann Surg2022-07-06T00:00:002022Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.35796581Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma NJournal of hepato-biliary-pancreatic sciencesComparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023 Apr; 30(4):523-531.J Hepatobiliary Pancreat Sci2022-07-15T00:00:002022Comparative analysis of opioid use between robotic and open pancreatoduodenectomy.Authorship 10505671535830887Janssen QP, van Dam JL, Prakash LR, Doppenberg D, Crane CH, van Eijck CHJ, Ellsworth SG, Jarnagin WR, O'Reilly EM, Paniccia A, Reyngold M, Besselink MG, Katz MHG, Tzeng CD, Zureikat AH, Groot Koerkamp B, Wei AC, Trans-Atlantic Pancreatic Surgery (TAPS) ConsortiumJournal of the National Comprehensive Cancer Network : JNCCNNeoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study. J Natl Compr Canc Netw. 2022 07; 20(7):783-791.e1.J Natl Compr Canc Netw2022-07-01T00:00:002022Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.Authorship 105097813Authorship 10508871135849783Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, Bai S, Hu M, Kumar T, Hurd MW, Katz MHG, Tzeng CD, Pant S, Javle M, Fogelman DR, Maitra A, Haymaker CL, Kim MP, Navin NE, Bernatchez CCancer discoverySingle-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer. Cancer Discov. 2022 10 05; 12(10):2330-2349.Cancer Discov2022-10-05T00:00:002022Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.35863672Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan SInternational journal of radiation oncology, biology, physicsNab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys. 2022 11 01; 114(3):444-453.Int J Radiat Oncol Biol Phys2022-07-18T00:00:002022Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation.Authorship 105453617Authorship 105943311Authorship 10589919Authorship 10612367Authorship 10605917Authorship 106018916Authorship 105738614Authorship 10564632Authorship 10606057Authorship 1056168436382087Morris VK, Overman MJ, Lam M, Parseghian CM, Johnson B, Dasari A, Raghav K, Kee BK, Huey R, Wolff RA, Shen JP, Li J, Zorrilla I, Tzeng CD, Tran Cao HS, Chun YS, Newhook TE, Vauthey N, Duose D, Luthra R, Haymaker C, Kopetz SCancer research communicationsBintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun. 2022 09; 2(9):979-986.Cancer Res Commun2022-09-14T00:00:002022Bintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer.36127553Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, Vellone M, Chun YS, Tzeng CD, Aloia TA, Giuliante F, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurvival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2022 12; 26(12):2503-2511.J Gastrointest Surg2022-09-20T00:00:002022Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases.36112251Newton AD, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HSAnnals of surgical oncologyRobotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.Ann Surg Oncol2022-09-16T00:00:002022Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis.35948035Hester CA, Perri G, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Tzeng CD, Smaglo B, Wolff R, Javle M, Overman MJ, Lee JE, Katz MHGJournal of the National Comprehensive Cancer Network : JNCCNRadiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer. J Natl Compr Canc Netw. 2022 08; 20(8):887-897.e3.J Natl Compr Canc Netw2022-08-01T00:00:002022Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer.36282600Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MPThe Journal of clinical investigation3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest. 2022 12 15; 132(24).J Clin Invest2022-12-15T00:00:0020223D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.36207173Martin AN, Concors SJ, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Katz MHG, Vauthey JN, Tzeng CDAmerican journal of surgeryIndividual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. 2022 Oct 01.Am J Surg2022-10-01T00:00:002022Individual components of post-hepatectomy care pathways have differential impacts on length of stay.36649067Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CDAnnals of surgeryPrognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg. 2023 03 01; 277(3):484-490.Ann Surg2022-12-26T00:00:002022Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.36697350Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TEHPB : the official journal of the International Hepato Pancreato Biliary AssociationImpact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.HPB (Oxford)2023-01-04T00:00:002023Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors.36443557Donovan EC, Prakash LR, Chiang YJ, Bruno ML, Maxwell JE, Ikoma N, Tzeng CD, Katz MHG, Lee JE, Kim MPJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractIncidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer. J Gastrointest Surg. 2023 02; 27(2):319-327.J Gastrointest Surg2022-11-29T00:00:002022Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer.35950790Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHGJournal of hepato-biliary-pancreatic sciencesQuality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.J Hepatobiliary Pancreat Sci2022-08-11T00:00:002022Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer.Authorship 10630707Authorship 1063084636715178Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EBThe oncologistBrain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.Oncologist2023-04-06T00:00:002023Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.36729595Erstad DJ, Hatanaka Y, Cass S, Maxwell J, Tran Cao H, Kim M, Tzeng CW, Lee JE, Katz M, Ikoma NJournal of the American College of SurgeonsTechnique for Robotic Pancreaticojejunostomy. J Am Coll Surg. 2023 05 01; 236(5):e12-e14.J Am Coll Surg2022-12-15T00:00:002022Technique for Robotic Pancreaticojejunostomy.Authorship 10635508Authorship 1063718436752968Hirata Y, Maxwell JE, Kim MP, Tzeng CD, Katz MHG, Ikoma NAnnals of surgical oncologyTransmesocolic Approach for Robotic Duodenal Operations. Ann Surg Oncol. 2023 05; 30(5):2959.Ann Surg Oncol2023-02-08T00:00:002023Transmesocolic Approach for Robotic Duodenal Operations.36746143Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang HThe American journal of surgical pathologyIntegrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol. 2023 04 01; 47(4):421-430.Am J Surg Pathol2023-02-06T00:00:002023Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.Authorship 106386112Authorship 1063855536781357Ayabe RI, Paez-Arango N, Estrella JS, Newhook TE, Tzeng CD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HSHPB : the official journal of the International Hepato Pancreato Biliary AssociationNeoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.HPB (Oxford)2023-01-24T00:00:002023Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?36786469Ayabe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CDJournal of the American College of SurgeonsDifferential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. J Am Coll Surg. 2023 07 01; 237(1):4-12.J Am Coll Surg2023-02-14T00:00:002023Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways.Authorship 10685415Authorship 1068606837026453Ngo-Huang AT, Parker NH, Xiao L, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHGAnnals of surgeryEffects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial. Ann Surg. 2023 07 01; 278(1):22-30.Ann Surg2023-04-07T00:00:002023Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial.37085394Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HSHPB : the official journal of the International Hepato Pancreato Biliary AssociationEvaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 Jul; 25(7):758-765.HPB (Oxford)2023-03-07T00:00:002023Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion.Authorship 10697498Authorship 10701832237149547Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JNAnnals of surgical oncologyBenchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911.Ann Surg Oncol2023-05-06T00:00:002023Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study.37174073Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang HCancersPrognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel). 2023 May 04; 15(9).Cancers (Basel)2023-05-04T00:00:002023Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.Authorship 10720768Authorship 10723088Authorship 107433313Authorship 10723747Authorship 10742888Authorship 1072138837330447Spitzer HV, Kemp Bohan PM, Carpenter EL, Adams AM, Chang SC, Grunkemeier G, Vreeland TJ, Tzeng CD, Katz MHG, Nelson DWAnnals of surgical oncologyImpact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma. Ann Surg Oncol. 2023 Oct; 30(11):6662-6670.Ann Surg Oncol2023-06-17T00:00:002023Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma.37370842Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang HCancersComparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel). 2023 Jun 18; 15(12).Cancers (Basel)2023-06-18T00:00:002023Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.37285096Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JNAnnals of surgical oncologyHepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.Ann Surg Oncol2023-06-07T00:00:002023Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.37322282Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JNAnnals of surgical oncologyASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.Ann Surg Oncol2023-06-15T00:00:002023ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer.37389897Boyev A, Arvide EM, Newhook TE, Prakash LR, Bruno ML, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CDAnnals of surgeryProphylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalation. Ann Surg. 2024 Apr 01; 279(4):657-664.Ann Surg2023-07-03T00:00:002023Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients With Biliary Stents: Opportunity for De-escalation.37344750Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JNAnnals of surgical oncologyCorrection: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5405.Ann Surg Oncol2023-09-01T00:00:002023Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.Authorship 10751391537468733Boyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD, Maxwell JEJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPostoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy. J Gastrointest Surg. 2023 10; 27(10):2135-2144.J Gastrointest Surg2023-07-19T00:00:002023Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy.Authorship 107771915Authorship 10782423Authorship 107811510Authorship 107765015Authorship 10772731237568706Rogers JE, Sirisaengtaksin A, Leung M, Morris VK, Xiao L, Huey R, Wolff R, Eng C, Vauthey JN, Tzeng CD, Johnson BCancersHepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach. Cancers (Basel). 2023 Jul 31; 15(15).Cancers (Basel)2023-07-31T00:00:002023Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach.37679537Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HSAnnals of surgical oncologyTreatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.Ann Surg Oncol2023-09-07T00:00:002023Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.37537494Maki H, Kim BJ, Kawaguchi Y, Fernandez-Placencia R, Haddad A, Panettieri E, Newhook TE, Baumann DP, Santos D, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Vreeland TJJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractIncidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.J Gastrointest Surg2023-08-03T00:00:002023Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases.37672236Boyev A, Jain AJ, Newhook TE, Prakash LR, Chiang YJ, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CDJAMA surgeryOpioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm. JAMA Surg. 2023 Nov 01; 158(11):e234154.JAMA Surg2023-11-01T00:00:002023Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm.37593365De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJLiver cancerDefinitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer. 2023 Aug; 12(3):198-208.Liver Cancer2023-03-16T00:00:002023Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases.Authorship 10798761237742542Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JESurgical oncologyElevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma. Surg Oncol. 2023 Dec; 51:101994.Surg Oncol2023-09-19T00:00:002023Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma.Authorship 10803691437791481Boyev A, Azimuddin A, Prakash LR, Newhook TE, Maxwell JE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CDAnnals of surgeryClassification of Post-Pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies. Ann Surg. 2023 Oct 04.Ann Surg2023-10-04T00:00:002023Classification of Post-Pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies.Authorship 10832681437935998Boyev A, Azimuddin A, Newhook TE, Maxwell JE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractEvaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. J Gastrointest Surg. 2023 Dec; 27(12):2806-2814.J Gastrointest Surg2023-11-07T00:00:002023Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria.Authorship 108379811Authorship 1084503538039992Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SEThe Lancet. OncologyStereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol. 2023 Dec; 24(12):1387-1398.Lancet Oncol2023-12-01T00:00:002023Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.37989954Jain AJ, Newhook TE, Lilley E, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HSAnnals of surgical oncologyA Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.Ann Surg Oncol2023-11-21T00:00:002023A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy.Authorship 10852851138129274Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CDAmerican journal of surgeryUtilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2023 Dec 15.Am J Surg2023-12-15T00:00:002023Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients.Authorship 108594310Authorship 10859283Authorship 1085948238148351Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TEAnnals of surgical oncologyLocal Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.Ann Surg Oncol2023-12-27T00:00:002023Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.38144503Fields BC, Boyev A, Tzeng CDAnnals of surgery open : perspectives of surgical history, education, and clinical approachesResponse to LTE on Prophylactic Antibiotic Duration. Ann Surg Open. 2023 Dec; 4(4):e345.Ann Surg Open2023-11-03T00:00:002023Response to LTE on Prophylactic Antibiotic Duration.38147123Hirata Y, Gottumukkala V, Ajith J, Schmeisser JA, Ninan EP, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Badgwell BD, Katz MHG, Ikoma NLangenbeck's archives of surgeryLaparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg. 2023 Dec 26; 409(1):16.Langenbecks Arch Surg2023-12-26T00:00:002023Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis.Authorship 10861604Authorship 108636410Authorship 10861449Authorship 1086247238159256Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AOThe oncologistDevelopment of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2023 Dec 30.Oncologist2023-12-30T00:00:002023Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.38170408Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N, Prakash LR, Theijse RT, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Trans-Atlantic Pancreatic Surgery (TAPS) ConsortiumAnnals of surgical oncologySerum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study. Ann Surg Oncol. 2024 Mar; 31(3):1919-1932.Ann Surg Oncol2024-01-03T00:00:002024Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.38182848Stoop TF, Doppenberg D, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Trans-Atlantic Pancreatic Surgery (TAPS) ConsortiumAnnals of surgical oncologyASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9. Ann Surg Oncol. 2024 03; 31(3):1842-1843.Ann Surg Oncol2024-01-05T00:00:002024ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9.38180055Azimuddin A, Tzeng CD, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Newhook TE, Kim MP, Ikoma N, Snyder RA, Lee JE, Perrier ND, Katz MH, Maxwell JEJournal of the American College of SurgeonsPostoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg. 2024 Apr 01; 238(4):451-459.J Am Coll Surg2024-03-15T00:00:002024Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways.Authorship 1088248538282027Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YSAnnals of surgical oncologyRevisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 Jan 28.Ann Surg Oncol2024-01-28T00:00:002024Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?Authorship 108835112Authorship 1088427838309721Amaria R, Knisely A, Vining D, Kopetz S, Overman MJ, Javle M, Antonoff MB, Tzeng CD, Wolff RA, Pant S, Lito K, Rangel K, Fellman B, Yuan Y, Lu KH, Sakellariou-Thompson D, Haymaker CL, Forget MA, Hwu P, Bernatchez C, Jazaeri AAJournal for immunotherapy of cancerEfficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. J Immunother Cancer. 2024 Feb 02; 12(2).J Immunother Cancer2024-02-02T00:00:002024Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.38315954Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B, Trans-Atlantic Pancreatic Surgery (TAPS) ConsortiumJournal of clinical oncology : official journal of the American Society of Clinical OncologyImproved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. J Clin Oncol. 2024 Feb 05; JCO2301311.J Clin Oncol2024-02-05T00:00:002024Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.Authorship 1088944538363196Albuquerque J, Lin YM, Paolucci I, O'Connor CS, Tzeng CW, Vauthey JN, Brock KK, Odisio BCRadiology. Imaging cancerIncidental Ring-hyperenhancing Liver Micronodules at CT Hepatic Arteriography-guided Percutaneous Thermal Ablation of Colorectal Liver Metastases. Radiol Imaging Cancer. 2024 Mar; 6(2):e230099.Radiol Imaging Cancer2024-03-01T00:00:002024Incidental Ring-hyperenhancing Liver Micronodules at CT Hepatic Arteriography-guided Percutaneous Thermal Ablation of Colorectal Liver Metastases.Authorship 1090137738456678Theijse RT, Stoop TF, Janssen QP, Prakash LR, Katz MHG, Doppenberg D, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MGThe British journal of surgeryImpact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study. Br J Surg. 2024 Mar 02; 111(3).Br J Surg2024-03-02T00:00:002024Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.Authorship 1091308238506042Cass SH, Tzeng CD, Prakash LR, Maxwell J, Snyder RA, Kim MP, Huey RW, Smaglo BG, Pant S, Koay EJ, Wolff RA, Lee JE, Katz MHG, Ikoma NAnnals of surgeryTrends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Ann Surg. 2024 Mar 20.Ann Surg2024-03-20T00:00:002024Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessor24033514Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TAHPB : the official journal of the International Hepato Pancreato Biliary AssociationPredictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014 May; 16(5):459-68.HPB (Oxford)2013-08-26T00:00:002013Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.24002535Lee S, Reha JL, Tzeng CW, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MHAnnals of surgical oncologyRace does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol. 2013 Dec; 20(13):4073-9.Ann Surg Oncol2013-09-04T00:00:002013Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system.